Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_540_Библиотеки_им_академика_М_И_Перельмана
.pdf
2.3 Perioperative Management
https://t.me/medicina_free
37
acids can prolong the duration of gestation by
4–7days and that dietary intake is marginal in
Western populations [156]. A dose-response relation reects an intake of up to 0.15g ω-3 fatty
acids [157].
2.3.3 Hemorrhage Management
2.3.3.1 Cardiopulmonary Resuscitation
Hypovolemia will manifest as thready pulses,
tachycardia, attened neck veins, pallor, and prolonged capillary rell. The systolic blood pressure is approximately 80mmHg if a radial pulse
BLS team actions ongoing
• High-quality chest compressions
• Defiboillation when indicated
• Monitor CPR quality
Maternal cardiac arrest team arrives
Maternal interventions
is palpable. The absence of carotid and peripheral
pulses indicates pulseless electrical activity, and
Advanced Cardiovascular Life Support (ACLS)
protocols should be initiated. If debrillation is
unnecessary, standard ACLS voltage should be
used (Fig.2.4).
There is no evidence that the current harms the
fetus from debrillation [159]. External fetal
monitors should be removed before delivering
shocks [159]. Chest compressions should be carried out to understand that the maternal heart is
displaced upward in the chest by the gravid uterus
at advanced gestations, guiding hand placement
[159].
Consider otiology
of cardiac arrest*
for patient whose uterus is at or above the umbilicus*
Obstetric interventions
Appropriate
airway
management
• Anticipate
the difficult
airway
• Most
experienced
provider
preferred
†
IV above
diaphragm
• Give typical
ACLS drugs
and dosages
• Assess for
hypovolemia
and give fluid
bolus +/- blood
products when
required
Potential etiology of maternal cardiac arrest:
• Anesthetic complications/accidents
• Bleedilg
• Cardiovascular
• Drugs
• Embolic
•
Fever
•
General nonobstetric causes of cardiac
arrest (H’s and T’s)
• Hypertension
If patient receiving
IV magnesium
prearrest, stop
magnesium and
give IV/IO calcium
chloride 10 mL in
10% solution or
calcium gluconate
30 mL in 10%
solution
Neonatal team:
• Prepare to
receive infant
†Appropriate airway management for pregnancy:
• 100% oxygen at >15 L/min and continue BLS airway strategies
• Optimally 2 attempts per technique:
– First intubation attempt—if failed go to
– Second intubation attempt—if failed go to
– First supraglottic airway attempt—if failed go to
– Second supraglotic airway attempts—if failed go to mask ventilation
– If mask ventilation inadequate—attempt cricothyrotomy
• Avoid airway trauma
• Ventilate with 8–10 breaths/min
• Monitor capnography
• Minimize interruptions in chest compressions during advanced airway
placement
• Recommend 6.0- to 7.0-mm inner diameter ERR
Continuous
manual LUD
• If no ROSC by 4 minutes of resuscitative
efforts, consider performing immediate
emergency cesarean delivery
Remove/
detach fetal
monitors
Fig. 2.4 Maternal cardiac arrest algorithm. (Reproduced with permission from [158])
Prepare for
emergency
cesarean
delivery

38
https://t.me/medicina_free
Cardiopulmonary resuscitation (CPR)
should not be interrupted to administer
medications because they get circulated
with compressions [160]. Administration
of medications in pregnancy through lower
extremity lines should be avoided because
they may not adequately reach the maternal
heart because of venous compression by
the gravid uterus [160].
Palpable femoral pulses are not reliable indicators of blood ow during CPR because the retrograde ow in the femoral vein could mimic
femoral artery pulsations [160]. A carotid pulse
during CPR is not an indicator of adequate cerebral or coronary blood ow [160]. An end-tidal
CO2 indicates adequate CPR and the return of
spontaneous circulation [160].
2.3.3.2 Major Hemorrhage
Major obstetric hemorrhageis a blood loss of
≥2500mL, transfusion of 5units of packed red
blood cells (pRBC), or treatment of a coagulopathy [161]. Transfusion of blood and blood products in trauma and major bleeding is changing
due to experience in military medicine.
Resuscitation in obstetric hemorrhage is similar
to that in trauma. Both aim to stop bleeding,
maintain efcient oxygen delivery, and prevent
the development of the “lethal triad”—acidosis,
hypothermia, and coagulopathy. Protocols for
debrillation and doses of medications remain
unchanged in pregnancy. Obstetric resuscitation
starts with the IV uids and pRBC, followed by
clotting products and platelets, often guided by
coagulation studies that delay treatment [162].
The UK National Patient Safety Agency recom-
mends monitoring laboratory blood tests during
massive transfusions and that administration of
blood and blood products should not be delayed
while awaiting results [161–163]. Resuscitation
of bleeding patients with crystalloid, colloid, and
plasma-poor pRBC simultaneously when clotting factors are consumed results in plasma coagulation factors falling to <40% and typically
occurs before 10units of pRBC have been given
2 Anesthetic andPerioperative Management
[164]. Disseminated intravascular coagulopathy
in obstetric hemorrhage can also occur early,
especially if the bleeding is not treated rapidly.
Early treatment of massive hemorrhage after
trauma using fresh frozen plasma (FFP) and
pRBC in a 1:1 ratio improves survival [164–167].
Military guidelines for hemorrhagic shock also
recommend the administration of platelets in a
1:1 ratio with pRBC [165–167].
Prevention of coagulopathy should be better
than its treatment and requires anticipation [164].
Some authors advise that clotting factors should
be replaced on clinical grounds rather than laboratory results [165, 167]. The Association of
Anesthetists of Great Britain and Ireland recommends an early infusion of FFP (15ml/kg) to prevent hemostatic failure. It may need to be started
if a senior clinician anticipates massive bleeding
[168]. This guideline emphasizes the importance
of preventing hemostatic failure because, once
established, standard regimens of FFP infusion
are likely to be inadequate and larger volumes
will be required with greater risk to the patient
and cost implications for the hospital [168].
A ratio of 6:4:1 for pRBC/FFP/platelets has
been suggested for massive obstetric bleeding. If
bleeding continues after initial treatment, consideration should be given to increasing an FFP to a
ratio of 4:4:1 [163].
Point-of-care tests can measure hemoglobin
concentration and the coagulation prole and
guide blood product replacement following initial resuscitation.
Fibrinogen concentrations are also greater in
pregnancy; the optimal posttransfusion brinogen concentration has been suggested as 1.0–
2.0 g/L [162]. The high ratios of pRBC to
coagulation products recommended for other
types of trauma may not be required in obstetric
patients. In contrast, greater replacement of
brinogen may be necessary. Evidence supports
a 1:1:1 ratio of pRBC/FFP/platelets in trauma,
but less in obstetrics [162, 165–167].
Maintenance of a platelet count of
50–100×109/l has been suggested and used as a
guide in conjunction with the patient’s clinical
condition [162]. pRBC/platelet ratios of 5:2 and
5:1 showed good results [162, 169]. Guidelines

References
https://t.me/medicina_free
39
suggest that recombinant factor VIIa (rFVIIa)
should be considered before hysterectomy if
hemostatic failure and hemorrhage continue
despite optimal blood product replacement and
obstetric management [162, 170]. Arterial thrombosis is a potential complication of rFVIIa use,
but has not been reported in a case series of 15
patients [170]. Its safety in the obstetric population is unproven with a signicant cost implication. Using thromboelastography and
thromboelastometry to guide optimum ratios of
blood product replacement during obstetric hemorrhage may be limited by the time during the
initial resuscitation phase, and there is limited
familiarity with their use in obstetrics
[161–163].
Liberal oxygen and uids administration
when the bicarbonate level is low improves tissue
perfusion and fetaloxygenation [171, 172].
2.3.3.3 Fetal Assessment
Fetal injury can result from major maternal
bleeding, direct fetal trauma (see Chap. 5), or
both.
References
1. ACOG Committee Opinion No. 775: nonobstetric surgery during pregnancy. Obstet Gynecol.
2019;133(4):e285–6.
2. Melnick DM, Wahl WL, Dalton VK.Management
of general surgical problems in the pregnant patient.
Am J Surg. 2004;187:170–80.
3. Rosen M.Management of anesthesia for the pregnant
surgical patient. Anesthesiology. 1999;91:1159–63.
4. Mazze RI, Källén B. Appendectomy during pregnancy: a Swedish registry study of 778 cases. Obstet
Gynecol. 1991;77(6):835–40.
5. Duncan PG, Pope WD, Cohen MM, Greer N.Fetal
risk of anesthesia and surgery during pregnancy.
Anesthesiology. 1986;64(6):790–4.
6. Koren G, Pastuszak A, Ito S.Drugs in pregnancy. N
Engl J Med. 1998;338(16):1128–37.
7. Kuczkowski KM. Nonobstetric surgery during
pregnancy: what are the risks of anesthesia? Obstet
Gynecol Surv. 2004;59(1):52–6.
8. Kilpatrick CC, Monga M. Approach to the acute
abdomen in pregnancy. Obstet Gynecol Clin North
Am. 2007;34:389–402.
9. Olutoye OA, Baker BW, Belfort MA, Olutoye
OO. Food and Drug Administration warning on
anesthesia and brain development: implications for
obstetric and fetal surgery. Am J Obstet Gynecol.
2018;218(1):98–102.
10. Upadya M, Saneesh PJ. Anaesthesia for nonobstetric surgery during pregnancy. Indian J Anaesth.
2016;60:234–41.
11. Bowman W.Neuromuscular block. Br J Pharmacol.
2006;147(S1):S277–86.
12. Nauheimer D, Kollath C, Geldner G. Modizierte
Blitzintubation im Kreißsaal: Fallserie zum Einsatz
von Rocuronium und Sugammadex. Anaesthesist.
2012;61(8):691–5.
13. Williamson RM, Mallaiah S, Barclay P.Rocuronium
and sugammadex for rapid sequence induction of
obstetric general anaesthesia. Acta Anaesthesiol
Scand. 2011;55(6):694–9.
14. Soyoral L, Goktas U, Cegin MB, Baydi V.Successful
use of sugammadex for caesarean section in a
patient with myasthenia gravis. Braz J Anesthesiol.
2017;67(2):221–2.
15. Et T, Topal A, Erol A, Tavlan A, Kılıçaslan A, Uzun
ST.The effects of sugammadex on progesterone levels in pregnant rats. Balkan Med J. 2015;32(2):203–7.
16. Torres SM, Duarte DF, Glória AS, Reis C, Moreira
JF, Cunha S, et al. Sugammadex administration in
pregnant patients undergoing non-obstetric surgery:
a case series. Braz J Anesthesiol. 2021;72:525–8.
17. Richardson MG, Raymond BL. Sugammadex
administration in pregnant women and in women
of reproductive potential: a narrative review. Anesth
Analg. 2020;130(6):1628–37.
18. Miao M, Zhang J.Does the pretreatment of magnesium sulphate affect the sugammadex reversal time
for rocuronium-induced neuromuscular blockade? A
meta-analysis. J Clin Anesth. 2020 Mar;1(60):78–9.
19. Bagci S, Tuzun A, Erdil A, Gulsen M, Dagalp
K. Treatment of choledocholithiasis in pregnancy: a case report. Arch Gynecol Obstet.
2003;267(4):239–41.
20. Simmons DC, Tarnasky PR, Rivera-Alsina ME,
Lopez JF, Edman CD.Endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy without the use of radiation. Am J Obstet Gynecol.
2004;190:1467–9.
21. Sungler PM, Steiner H, etal. Laparoscopic cholecystectomy and interventional endoscopy for gallstone complications during pregnancy. Surg Endosc.
2000;14:267–71.
22. Mercier FJ, Augè M, Hoffmann C, Fischer C,
Le Gouez A. Maternal hypotension during spinal anesthesia for caesarean delivery. Minerva
Anestesiol. 2013;79:62–73.
23. Onuki E, Higuchi H, Takagi S, Nishijima K, Fujita
N, Matsuura T, etal. Gestation-related reduction in
lumbar cerebrospinal uid volume and dural sac surface area. Anesth Analg. 2010;110:148–53.
24. OzkanSeyhan T, Orhan-Sungur M, Basaran B,
Savran Karadeniz M, Demircan F, Xu Z, etal. The
effect of intra-abdominal pressure on sensory block
level of single-shot spinal anesthesia for cesarean

40
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
section: an observational study. Int J Obstet Anesth.
2015;24:35–40.
25. Kuok CH, Huang CH, Tsai PS, Ko YP, Lee WS, Hsu
YW, et al. Preoperative measurement of maternal
abdominal circumference relates the initial sensory
block level of spinal anesthesia for cesarean section:
an observational study. Taiwan J Obstet Gynecol.
2016;55:810–4.
26. Nordin H, Unosson M, etal. Type of anaesthesia and
patient acceptance in groin hernia repair: a multicentrerandomised trial. Hernia. 2004;8:220–5.
27. Gordon M. Maternal physiology in pregnancy.
In: Gabbe SG, Niebyl JR, Simpson J, editors.
Obstetrics: normal and problem pregnancies. 6th ed.
Philadelphia: Saunders Elsevier; 2012.
28. Koonin LM, Mackay AP, Berg CJ, Atrash HK, Smith
JC. Pregnancy-related mortality surveillance—
United States, 1987-1990. MMWR CDC Surveill
Summ. 1997;46(4):17–36.
29. Jain V, Chari R, Maslovitz S, Farine D, Maternal
Fetal Medicine Committee, Bujold E, et al.
Guidelines for the management of a pregnant trauma
patient. J Obstet Gynaecol Can. 2015;37(6):553–74.
30. Cheek TG, Baird E.Anesthesia for nonobstetric surgery: maternal and fetal considerations. Clin Obstet
Gynecol. 2009;52(4):535–45.
31. Pedersen H, Finster M.Anesthetic risk in the pregnant
surgical patient. Anesthesiology. 1979;51:439–51.
32. Dudley H, Gatewood T, etal. Delayed traumatic rupture of the diaphragm in pregnancy. Obstet Gynecol.
1979;53:25S–7S.
33. Lobb TR, Butlin GR. Anaesthesia and traumatic diaphragmatic hernia. Can Anaesth Soc J.
1974;21:173–80.
34. Loehning RW, Safar P, Takaori M.Circulatory collapse from anesthesia for diaphragmatic hernia.
Arch Surg. 1965;90:109–13.
35. Williams M, Appelboam R, McQuillan
P. Presentation of diaphragmatic herniae during pregnancy and labour. Int J Obstet Anesth.
2003;12:130–4.
36. Ouzounian JG, Elkayam U. Physiologic changes
during normal pregnancy and delivery. Cardiol Clin.
2012;30:317–29.
37. Rajaram SS, Desai NK, Kalra A, Gajera M,
Cavanaugh SK, Brampton W, et al. Pulmonary
artery catheters for adult patients in intensive care.
Cochrane Database Syst Rev. 2013;2013:CD003408.
38. Kuczkowski KM, Benumof JL, Ispirescu JS.Trauma
in pregnancy: anesthetic management of the parturient with multiple gunshot wounds to the gravid
uterus and fetal injury. J Trauma. 2003;54:420.
39. Pilkington F, Dakin MJ, et al. Increase in
Mallampati score during pregnancy. Br J Anaesth.
1995;74:638–42.
40. Sakles JC, Chiu S, Josephy CP. Success rates of
Glidescope video laryngoscopy versus direct laryngoscopy in blunt trauma patients with cervical
immobilization. J Emerg Med. 2009;27:220.
41. Kuczkowski K.Peripartum anaesthetic management
of a parturient with spinal cord injury and autonomic
hyperreexia. Anaesthesia. 2003;58:823–4.
42. Kuczkowski KM, Benumof JL, Reisner LS.Airway
problems and new solutions for the obstetric patient.
J Clin Anesth. 2003;15:552–62.
43. Warner D. Neuroanesthesia 2000. Anesth Analg.
2000;90:1238–40.
44. Popov F, Mantel G, etal. Acute spinal cord injury in
pregnancy: an illustrative case and literature review.
J Obstet Gynaecol. 2003;23:596–8.
45. Pelosi P, Quintel M, Malbrain MLNG. Effect of
intra-abdominal pressure on respiratory mechanics.
Acta Clin Belg. 2007;62(Suppl 1):78–88.
46. Lozada JM, Goyal V, Levin D, Walden RL,
Osmudson SS, Pacheco LD, et al. Management
of peripartum intra-abdominal hypertension and
abdominal compartment syndrome. Acta Obstet
Gynecol Scand. 2019;98:1386–97.
47. Silvestri CM, Brousseau EC, et al. Morbidity
of appendectomy and cholecystectomy in pregnant and non-pregnant women. Obstet Gynecol.
2011;118:1261–70.
48. Schrinsky DC, Benson RC. Rupture of the pregnant uterus: a review. Obstet Gynecol Surv.
1978;33:217–32.
49. Dhaifalah I, Santavy J, Fingerova H.Uterine rupture during pregnancy and delivery among women
attending the Al-Tthawra Hospital in Sana’a City
Yemen republic. In: Biomedical papers of the medical Faculty of the University Palack??, Olomouc,
Czechoslovakia, vol. 150; 2006. p.279–83.
50. Lachman E, Moodley J, Pitsoe SB, Philpott
RH. Rupture of the gravid uterus. S Afr Med J.
1985;67:333–5.
51. Gafn SL, Grinberg Z, Abraham C, Birkhan J,
Shechter Y. Protection against hemorrhagic shock
in the cat by human plasma containing endotoxinspecic antibodies. J Surg Res. 1981;31(1):18–21.
52. Abbas AM, Ali SS, Farouk H, Nasif F, Khalifa MA,
Abdelkader AM. Spontaneous unscarred uterine
rupture in Primigravida with breech term fetus. J
Gynecol Surg. 2018;34:89–91.
53. Wang YL, Su TH, Lee RKK.Obstetric uterine rupture: a 20-year clinical analysis. Taiwan J Obstet
Gynecol. 2004;43:136–9.
54. Dixon SJ, O’Leary TD, Perez JLC. Spontaneous
complete uterine rupture in a nonlaboring, early
third-trimester uterus: missed diagnosis by ultrasound. Am J Perinatol Rep. 2013;3:79–82.
55. Khabbaz AY, Usta IM, El-Hajj MI, Abu-Musa
A, Seoud M, Nassar AH.Rupture of an unscarred
uterus with misoprostol induction: case report
and review of the literature. J Matern Fetal Med.
2001;10(2):141–5.
56. Fabamwo A, Akinola O, Tayo A, Akpan E.Rupture
of the gravid uterus: a never-ending obstetric disaster! The Ikeja experience. Int J Gynecol Obstet.
2008;10:2.

References
https://t.me/medicina_free
41
57. Soper NJ, Petrie RH, Hunter JG. Laparoscopic
cholecystectomy during pregnancy. Surg Endosc.
1992;6:115–7.
58. Comitalo JB, Lynch D.Laparoscopic cholecystectomy in the pregnant patient. Surg Laparosc Endosc.
1994;4:268–71.
59. Bhavani-Shankar K, Steinbrook RA, Brooks DC,
Datta S.Arterial to end-tidal carbon dioxide pressure
difference during laparoscopic surgery in pregnancy.
Anesthesiology. 2000;93(2):370–3.
60. Afeck DG, Handrahan DL, Egger MJ, Price
RR. The laparoscopic management of appendicitis and cholelithiasis during pregnancy. Am J Surg.
1999;178(6):523–9.
61. Rollins MD, Chan KJ, Price RR.Laparoscopy for
appendicitis and cholelithiasis during pregnancy:
a new standard of care. In: Surgical endoscopy
and other interventional techniques, vol. 18; 2004.
p.237–41.
62. Fatum M, Rojansky N.Laparoscopic surgery during
pregnancy. Obstet Gynecol Surv. 2001;56:50–9.
63. Dubar G, Azria E, Tesnière A, Dupont H, Le Ray
C, Baugnon T, etal. French experience of 2009 A/
H1N1v inuenza in pregnant women. PloS One.
2010;5(10):e13112.
64. Nair P, Davies AR, Beca J, Bellomo R, Ellwood D,
Forrest P, etal. Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum
women during the 2009 H1N1 pandemic. Intensive
Care Med. 2011;37(4):648–54.
65. Nnaoma C, Chika-Nwosuh OZ, Isedeh A, Bustillo J,
Twal AL, Patel P.Venovenous extracorporeal membrane oxygenation in a gravid patient with acute
respiratory distress syndrome: a case report. Am J
Case Rep. 2019;20:705.
66. Smith IJ, Gillham MJ. Fulminant peripartum
cardiomyopathy rescue with extracorporeal
membranous oxygenation. Int J Obstet Anesth.
2009;18(2):186–8.
67. Viau-Lapointe J, Filewod N. Extracorporeal therapies for amniotic uid embolism. Obstet Gynecol.
2019;134(5):989–94.
68. Pacheco LD, Clark SL, Klassen M, Hankins
GD. Amniotic uid embolism: principles of early
clinical management. Am J Obstet Gynecol.
2020;222(1):48–52.
69. Plotkin JS, Shah JB, Loand GK, DeWolf
AM.Extracorporeal membrane oxygenation in the
successful treatment of traumatic adult respiratory
distress syndrome: case report and review. J Trauma.
1994;37(1):127–30.
70. Broussard CN, Richter JE. Treating gastroesophageal reux disease during pregnancy and lactation: what are the safest therapy options. Drug Saf.
1998;19:325–37.
71. Costa SH, Vessey MP. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet.
1993;341:1258–61.
72. Cappell M. Colon cancer during pregnancy: the
gastroenterologist’s perspective. Gastroenterol Clin
North Am. 1998;27(1):225–56.
73. Hale M, Pearl RH, etal. Appendectomy: a contemporary appraisal. Ann Surg. 1997;225:252–61.
74. Andersen B, Nielsen TF.Appendicitis in pregnancy:
diagnosis, management and complications. Acta
Obstet Gynecol Scand. 1999;78:758–62.
75. Al-Mulhim A.Acute appendicitis in pregnancy. A
review of 52 cases. Int Surg. 1996;81:295–7.
76. Diav-Citrin S, Gotteiner T, et al. Pregnancy outcome after gestational exposure to metronidazole:
a prospective controlled cohort study. Teratology.
2001;63:186–92.
77. Burtin A, Ariburnu O, etal. Safety of metronidazole
in pregnancy: a meta-analysis. Am J Obstet Gynecol.
1995;172:525–9.
78. Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright
BJ, Ansaloni L, et al. Antimicrobials: a global
alliance for optimizing their rational use in intraabdominal infections (AGORA). World J Emerg
Surg. 2016;11(1):33.
79. Alano MA, Ngougmna E, Ostrea EM Jr, Konduri
GG. Analysis of nonsteroidal antiinammatory
drugs in meconium and its relation to persistent
pulmonary hypertension of the newborn. Pediatrics.
2001;107:519–23.
80. Corby D.Aspirin in pregnancy: maternal and fetal
effects. Pediatrics. 1978;62:930–45.
81. Levin D.Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin
synthetase inhibitors. J Pediatr. 1978;92:478–83.
82. Major DF, Harding JA, etal. Tocolysis with indomethacin increases the incidence of necrotizing
enterocolitis in the low-birth-weight neonate. Am J
Obstet Gynecol. 1994;170:102–6.
83. Moise JC, Sharif DS, etal. Indomethacin in the treatment of premature labor: effects on the fetal ductus
arteriosus. N Engl J Med. 1988;319:327–31.
84. Rumack CM, Guggenheim MA, Rumack BH,
Peterson RG, Johnson ML, Braithwaite WR.
Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol. 1981;58(5
Suppl):52S–6S.
85. Nielsen GL, Larsen H, Pedersen L, Sørensen
HT.Risk of adverse birth outcome and miscarriage
in pregnant users of non-steroidal antiinammatory
drugs: population based observational study and
case-control study. BMJ. 2001;322:266–70.
86. Li DK, Liu L, Odouli R.Exposure to non-steroidal
anti-inammatory drugs during pregnancy and risk
of miscarriage: population based cohort study. BMJ.
2003;327:368.
87. Antonucci R, Zaffanello M, Puxeddu E, Porcella
A, Cuzzolin L, Pilloni MD, et al. Use of nonsteroidal anti-inammatory drugs in pregnancy:
impact on the fetus and newborn. Curr Drug Metab.
2012;13(4):474–90.

42
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
88. Dawood M. Nonsteroidal antiinammatory
drugs and reproduction. Am J Obstet Gynecol.
1993;169:1255–65.
89. Van der Weiden RM, Keirse MJ, Helmerhorst
FM. Inuence of prostaglandins and platelet
activating factor on implantation. Hum Reprod.
1991;6:436–42.
90. Van der Weiden RM, Wouters JM. Infertility may
sometimes be associated with non-steroidal antiinammatory drug consumption. Br J Rheumatol.
1997;36:605.
91. Shintaku Hori S, Satoh H, et al. Prediction and
evaluation of fetal toxicity induced by NSAIDs
using transplacental kinetic parameters obtained
from human placental perfusion studies. Br J Clin
Pharmacol. 2012;73:248–56.
92. SIGN) SIGN. Prevention and management of
venous thromboembolism. A national clinical guideline. Edinburgh; 2010.
93. Bain E, Tooher R, Wilson A, etal. Prophylaxis for
venous thromboembolic disease in pregnancy and
the early postnatal period. Cochrane Database Syst
Rev. 2014;(2):CD001689.
94. Heit JA, Kobbervig CE, James AH, etal. Trends in
the incidence of venous thromboembolism during
pregnancy or postpartum: a 30-year populationbased study. Ann Intern Med. 2005;143(10):697.
95. Simpson EL, Nightingale AL, Farmer RD, et al.
Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a
London perinatal database. BJOG. 2001;108:56–60.
96. Anderson FA, Spencer FA. Risk factors for venous
thromboembolism. Circulation. 2003;107:19.
97. Bates SM, Greer IA, Middeldorp S, Veenstra DL,
Prabulos AM, Vandvik PO. VTE, thrombophilia,
antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines. Chest.
2012;141(2):e691S–736S.
98. Romero A, Alonso C, Rincon M, Medrano J, Santos
JM, Calderon E, et al. Risk of venous thromboembolic disease in women. A qualitative systematic review. Eur J Obstet Gynecol Reprod Biol.
2005;121(1):8–17.
99. Stirling Y, Woolf L, North WRS. Haemostasis
in normal pregnancy. Thromb Haemost.
1984;52(2):176–82.
100. Virkus EC, Bergholt T, etal. Venous thromboembolism in pregnant and puerperal women in Denmark
1995-2005. A national cohort study. Thromb
Haemost. 2011;106:304–9.
101. Gerhardt A, Scharf RE, Beckmann MW, Struve S,
Bender HG, Pillny M, etal. Prothrombin and factor
V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J
Med. 2000;342(6):374–80.
102. Jacobsen AF, Sandset PM, Skjeldestad
FE.Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-
based case-control study. Am J Obstet Gynecol.
2008;198(233):e1–7.
103. Brenner B. Haemostatic changes in pregnancy.
Thromb Res. 2004;114:409–14.
104. Toglia MR, Weg JG.Venous thromboembolism during pregnancy. N Engl J Med. 1996;335:108–14.
105. Caprini JA, Arcelus JI, Laubach M, Size G, Hoffman
KN, Coats RW, etal. Postoperative hypercoagulability and deep-vein thrombosis after laparoscopic cholecystectomy. Surg Endosc. 1995;9(3):304–9.
106. Davis E, Hickton C, etal. Inuence of spinal and
general anaesthesia on hemostasis during total hip
arthroplasty. Br J Anaesth. 1987;59:561–71.
107. Crozier TA, Muller JE, Quittkat D, Sydow M,
Wuttke W, Kettler D. Effect of anaesthesia on
the cytokine responses to abdominal surgery. Br J
Anaesth. 1994;72(3):280–5.
108. Shenkin A, Fraser WD, Series J, Winstanley FP,
McCartney AC, Burns HJ, etal. The serum interleukin 6 response to elective surgery. Lymphokine Res.
1989;8(2):123–7.
109. Avall A, Hyllner M, Bengtson JP, Carlsson L,
Bengtsson A.Postoperative inammatory response
after autologous and allogeneic blood transfusion.
Anesthesiology. 1997;87(3):511–6.
110. Tsiminikakis N, Chouillard E, Tsigris C, Diamantis
T, Bongiorni C, Ekonomou C, et al. Fibrinolytic
and coagulation pathways after laparoscopic and
open surgery: a prospective randomized trial. Surg
Endosc. 2009;23(12):2762–9.
111. Soriano D, Yefet Y, Oelsner G, Goldenberg M,
Mashiach S, Seidman DS. Operative laparoscopy for
management of ectopic pregnancy in patients with
hypovolemic shock. J Am Assoc Gynecol Laparosc.
1997;4(3):363–7.
112. Nguyen NT, Luketich JD, Shurin MR, Schatz S,
Tran Q, Ravid J, etal. Coagulation modications
after laparoscopic and open cholecystectomy in a
swine model. Surg Endosc. 1998;12(7):973–8.
113. Prisco D, De Gaudio AR, Carla R, Gori AM, Fedi S,
Cella AP, etal. Videolaparoscopic cholecystectomy
induces a hemostasis activation of lower grade than
does open surgery. Surg Endosc. 2000;14(2):170–4.
114. Dexter SP, Grifth JP, Grant PJ, McMahon
MJ. Activation of coagulation and brinolysis
in open and laparoscopic cholecystectomy. Surg
Endosc. 1996;10(11):1069–74.
115. Vander Velpen F, Kerremans R, etal. Interleukin-6
and coagulation-brinolysis uctuations after laparoscopic and conventional cholecystectomy. Surg
Endosc. 1994;8:1216–20.
116. Schietroma M, Carlei F, Mownah A, Franchi L,
Mazzotta C, Sozio A, etal. Changes in the blood
coagulation, brinolysis, and cytokine prole during laparoscopic and open cholecystectomy. Surg
Endosc. 2004;18:1090–6.
117. Begos DG, Modlin IM. Laparoscopic cholecystectomy: from gimmick to gold standard. J Clin
Gastroenterol. 1994;19(4):325–30.

References
https://t.me/medicina_free
43
118. Jorgensen K, Lalak NJ, etal. Thromboembolic complications of laparoscopic cholecystectomy. BMJ.
1993;306:518–9.
119. Dabrowiecki S, Jurkowski P, Rosc D. The inuence of laparoscopic cholecystectomy on perioperative blood clotting and brinolysis. Blood Coagul
Fibrinolysis. 1997;8:1–5.
120. Nguyen GC, Boudreau H, Harris ML, Maxwell
CV. Outcomes of obstetric hospitalizations
among women with inammatory bowel disease
in the United States. Clin Gastroenterol Hepatol.
2009;7(3):329–34.
121. Novacek G, Weltermann A, Sobala A, Tilg H,
Petritsch W, Reinisch W, et al. Inammatory bowel
disease is a risk factor for recurrent venous thromboembolism. Gastroenterology. 2010;139(3):779–87,
787 e1.
122. Greer IA, Nelson-Piercy C. Low-molecularweight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy:
a systematic review of safety and efcacy. Blood.
2005;106:401–7.
123. Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari
F, Letourneau N, etal. Pregnant women with inammatory bowel disease are at increased risk of vitamin
D insufciency: a cross-sectional study. J Crohns
Colitis. 2018;12:702–9.
124. Biswas P, Schultis SA, etal. Torsion of the gravid
uterus. A report of two cases. J Reprod Med.
1990;35:194–7.
125. Cook KE, Jenkins SM. Pathologic uterine torsion
associated with placental abruption, maternal shock,
and intrauterine fetal demise. Am J Obstet Gynecol.
2005;192:2082–3.
126. Cipullo LMA, van Oudgaarden ED, Milosavljevic
S.Uterus didelphys: report of a puerperal torsion and
a review of the literature. Case Rep Obstet Gynecol.
2012;2012:190167.
127. Fouad MA, Pathania AG, Marouf R.Primary mesenteric venous thrombosis in a 28-week pregnant
woman. Med Princ Pract. 2001;10(4):204–6.
128. Hmoud B, Singal AK, Kamath PS.Mesenteric venous
thrombosis. J Clin Exp Hepatol. 2014;4(3):257.
129. Chan CM, Chen WL, Chen JH, Wu YL, Huang
CC. Pregnancy-induced acute intestinal infarction
in a woman with chronic idiopathic mesenteric vein
thrombosis under regular anticoagulation treatment.
Med Princ Pract. 2009;18(5):422–4.
130. Kumar S, Sarr MG, Kamath PS.Mesenteric venous
thrombosis. N Engl J Med. 2001;345(23):1683–8.
131. Nelson SM. Venous thrombosis during assisted
reproduction: novel risk reduction strategies.
Thromb Res. 2013;131(Suppl 1):S1.
132. Nelson S. Prophylaxis of VTE in women – during assisted reproductive techniques. Thromb Res.
2009;123(Suppl):S8–S15.
133. Guan X, Huang L, Li L.Acute mesenteric venous
thrombosis in a pregnant woman at 35 weeks of
gestation: a case report and review of the literature.
BMC Pregnancy Childbirth. 2018;18(1):1–6.
134. Yapar EG, Bilge Ü, Dumanli H, Vural T, Gökmen
O.Portal vein thrombosis concomitant with thrombophilia during pregnancy. Eur J Obstet Gynecol
Reprod Biol. 1996;68(1–2):213–7.
135. Rollins MD, Price RR, Chan KJ.Laparoscopy for
appendicitis and cholelithiasis during pregnancy: a
new standard of care. Surg Endosc. 2004;18:237–41.
136. Afeck DG, Egger MJ, Price RR, Handrahan
DL. The laparoscopic management of appendicitis and cholelithiasis during pregnancy. Am J Surg.
1999;178:523–9.
137. Glasgow BC, Harris HW, etal. Changing management of gallstone disease during pregnancy. Surg
Endosc. 1998;12:241–6.
138. Graham G, Tharakan T, Baxi L. Laparoscopic
cholecystectomy during pregnancy: a case series
and review of the literature. Obstet Gynecol Surv.
1998;53:566–74.
139. Fukuda K, Masuoka J, Takada S, Katsuragi S, Ikeda
T, Iihara K.Utility of intraoperative fetal heart rate
monitoring for cerebral arteriovenous malformation surgery during pregnancy. Neurol Med Chir
(Tokyo). 2014;54:819–23.
140. Singh N, Mohanty CR, Nayak BM, Mohanty
GS.Point-of-care ultrasonography for fetal monitoring during non-obstetrical maternal surgery in the
second trimester. Can J Anesth. 2019;66:742–3.
141. Lu EJ, Curet MJ, El-Sayed YY, Kirkwood
KS. Medical versus surgical management of
biliary tract disease in pregnancy. Am J Surg.
2004;188:755–9.
142. Lisenbee N, Tyndall JA.Fetal heart rate monitoring. In: Atlas of emergency medicine procedures.
NewYork, NY: Springer; 2016. p.640–1.
143. Immer-Bansi FF, Henle S, etal. Unnecessary emergency caesarean section due to silent C.T.G. during
anaesthesia. Br J Anaesth. 2001;87:791–3.
144. Cosenza B, Jabbour N, etal. Surgical management
of biliary gallstone disease during pregnancy. Am J
Surg. 1999;178:545–8.
145. Wang CJ, Yen CF, Lee CL, Soong
YK. Minilaparoscopic cystectomy and appendectomy in late second trimester. JSLS. 2002;6:373–5.
146. Steinbrook RA, Brooks DC, Datta S.Laparoscopic
cholecystectomy during pregnancy. Review of anesthetic management, surgical considerations. Surg
Endosc. 1996;10(5):511–5.
147. Schnitker MA, Mattman PE, Bliss TL. A clinical
study of malnutrition in Japanese prisoners of war.
Ann Intern Med. 1951;35:69–96.
148. Solomon SM, Kirby DF.The refeeding syndrome: a
review. J Parenter Enteral Nutr. 1989;14:90–7.
149. Perdue PW, Johnson HW Jr, Stafford PW.Intestinal
obstruction complicating pregnancy. Am J Surg.
1992;164(4):384–8.
150. Levine MG, Esser D. Total parental nutrition for
the treatment of hyperemesis gravidarum: maternal nutritional effects and fetal outcome. Obstet
Gynecol. 1988;72:102–7.

44
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
151. Lee RV, Rodgers BD, Young C, Eddy E, Cardinal
J.Total parental nutrition during pregnancy. Obstet
Gynecol. 1986;68:563–71.
152. Ács N, Bánhidy F, Puhó EH, Czeizel AE.Possible
association between symptomatic cholelithiasiscomplicated cholecystitis in pregnant women and
congenital abnormalities in their offspring—a
population-based case-control study. Eur J Obstet
Gynecol Reprod Biol. 2009;146(2):152–5.
153. Czeizel AE, Acs N, Banhidy F, Puho EH, Vogt
G. Primary prevention of congenital abnormalities
due to high fever related maternal diseases by antifever therapy and folic acid supplementation. Curr
Women Health Rev. 2007;3(3):190–201.
154. Swisher PJ, Hunt KK, etal. Biliary disease during
pregnancy. Am J Surg. 1994;168:576–81.
155. Yang W, Shaw GM, Carmichael SL, Rasmussen
SA, Waller DK, Pober BR, etal. Nutrient intakes in
women and congenital diaphragmatic hernia in their
offspring. Birth Defects Res A Clin Mol Teratol.
2008;82:131–8.
156. Facchinetti F, Venturini P, Fazzio M.Polyunsaturated
fatty acids and risk of preterm delivery. Eur Rev Med
Pharmacol Sci. 2005;9:41–8.
157. Olsen SF, Secher NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm
delivery: prospective cohort study. BMJ. 2002;
324:447.
158. Kikuchi J, Deering S.Cardiac arrest in pregnancy.
Semin Perinatol. 2018;42(1):33–8.
159. Vanden Hoek TL, Morrison LJ, Shuster M, Donnino
M, Sinz E, Lavonas EJ, etal. Part 12: cardiac arrest in
special situations: 2010 American Heart Association
guidelines for cardiopulmonary resuscitation
and emergency cardiovascular care. Circulation.
2010;122:S829.
160. Link MS, Berkow LC, Kudenchuk PJ, Halperin HR,
Hess EP, Moitra VK, etal. Part 7: adult advanced
cardiovascular life support: 2015 American Heart
Association guidelines update for cardiopulmonary
resuscitation and emergency cardiovascular care.
Circulation. 2015;132(18):S444–64.
161. Wise A, Clark V. Strategies to manage major
obstetric haemorrhage. Curr Opin Anaesthesiol.
2008;21:281–7.
162. Mercier FJ, Bonnet MP.Use of clotting factors and
other prohemostatic drugs for obstetric hemorrhage.
Curr Opin Anaesthesiol. 2010;23(3):310–6.
163. Burtelow M, Riley E, Druzin M, Fontaine M, Viele
M, Goodnough LT.How we treat: management of
life-threatening primary postpartum hemorrhage
with a standardized massive transfusion protocol.
Transfusion (Paris). 2007;47(9):1564–72.
164. Ketchum L, Hess JR, Hiippala S. Indications for
early fresh frozen plasma, cryoprecipitate, and
platelet transfusion in trauma. J Trauma. 2006;60(6
Suppl):S51–8.
165. Jansen JO, Thomas R, Loudon MA, Brooks
A. Damage control resuscitation for patients with
major trauma. BMJ. 2009;338:b1778.
166. Borgman MA, Spinella PC, Perkins JG, Grathwohl
KW, Repine T, Beekley AC, etal. The ratio of blood
products transfused affects mortality in patients
receiving massive transfusions at a combat support
hospital. J Trauma. 2007;63(4):805–13.
167. Kirkman E, Watts S, Hodgetts T, Mahoney P,
Rawlinson S, Midwinter M.A proactive approach
to the coagulopathy of trauma: the rationale and
guidelines for treatment. J R Army Med Corps.
2007;153(4):302–6.
168. Thomas D, Wee M, Clyburn P, Walker I, Brohi K,
Collins P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage.
Anaesthesia. 2010;65:1153–61.
169. Gunter OL, Ames BK, Isbell J, Mowery NT, Young
PP, Cotton BA. Optimizing outcomes in damage
control resuscitation: identifying blood product
ratios associated with improved survival. J Trauma.
2008;65(3):527–34.
170. Bomken C, Mathai S, Biss T, Loughney A, Hanley
J.Recombinant activated factor VII (rFVIIa) in the
management of major obstetric haemorrhage: a
case series and a proposed guideline for use. Obstet
Gynecol Int. 2009;2009:364843.
171. Scorpio RJ, Esposito TJ, Smith LG, Gens DR.Blunt
trauma during pregnancy: factors affecting fetal outcome. J Trauma. 1992;32:213–6.
172. Esposito TJ, Gens DR, Smith LG, Scorpio R,
Buchman T, Trauma during pregnancy. A review of
79 cases. Arch Surg. 1991;126(9):1073–8.

Increased Intra-abdominal
https://t.me/medicina_free
Pressure
3
Abstract
Normal pregnancy leads to chronically
increased intra-abdominal pressure (IAP).
Pregnancy is a condition where multiple factors such as obesity, preeclampsia, or postpartum hemorrhage may lead to the overdiagnosis
of abdominal compartment syndrome (ACS).
When raised IAP is detected and treated, ACS
may often be avoided, especially with the
adoption of newer resuscitation strategies.
There is little data regarding physiologic and
pathophysiologic IAP in pregnancy. Current
consensus guidelines group pregnancy and
morbid obesity together as chronically compensated intra-abdominal hypertension (IAH)
states. Both operative and nonoperative conditions can cause increased IAP. Despite the
limited understanding of IAH in maternal
care, even less is known regarding its effects
on the fetus. Whether there are subclinical
effects of even modest elevations of maternal
IAP on the fetus is completely unknown.
Therefore, IAP should be measured in all critically ill pregnant patients. Treatment options,
including nonoperative and operative strategies, for its normalization should be carried
out immediately after verifying increased IAP
in pregnancy.
3.1 Physiology
andPathophysiology
3.1.1 Introduction
In the second and third trimesters of pregnancy,
the uterus occupies a major part of the abdominal
cavity. Due to hormonal inuences during pregnancy, the abdominal wall slowly stretches,
increasing its compliance and reducing the potential for increased IAP caused by the expanding
uterus. As a result, end-organ dysfunction, as in
critically ill patients with acute primary or secondary IAH, is rare because the body has time to
adapt to the slowly increasing IAP levels during
pregnancy. However, acute IAP increase from
any cause (e.g., bleeding or pneumoperitoneum
during laparoscopy) compromises uterine and
fetal perfusion [1].
Obstetric patients require admission to critical care units at rates ranging from <1% of deliveries in high-income countries to 2–43.6% in
low- to middle-income countries [2–4]. The
mortality rate of these women ranges from <1%
to >40% [3]. The most common causes of intensive care unit admission include hypertensive
disorders of pregnancy, bleeding, and infection
or sepsis [2, 3]. Each of these is an independent
risk factor for intra-abdominal hypertension
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
G. Augustin, Acute Abdomen During Pregnancy, https://doi.org/10.1007/978-3-031-26021-6_3
45

46
https://t.me/medicina_free
3 Increased Intra-abdominal Pressure
(IAH) and abdominal compartment syndrome
(ACS) [5, 6]. These illnesses, most commonly
preeclampsia and obstetric hemorrhage, can
result in signicant morbidity and mortality in
both mother and newborn [7, 8]. Further complicating the situation, intensivists are often unfamiliar with maternal- fetal physiology in health
and critical illness, including the possible impact
of increased intra- abdominal pressure (IAP) and
IAH on such conditions [7]. Pregnancy is a condition where multiple factors such as obesity,
preeclampsia, or postpartum hemorrhage may
lead to the overdiagnosis of ACS.Fortunately,
the incidence of IAH in critically ill obstetric
patients is only 6% [9].
The rst seminal work about IAH in pregnancy is from 1913 by an obstetrician Paramore,
Hunterian Professor of the Royal College of
Surgeons of England [10].
3.1.2 The Physiology ofNormal
Pregnancy
The maternal physiologic changes are multisystemic during pregnancy due to the adaptation to
accommodate the gravid uterus. On average, the
uterus contributes 1kg to the overall weight gain
in pregnancy, while the amniotic uid, fetus, and
placenta comprise approximately 5 kg in additional weight [11]. To accommodate uterine
growth, the thoracic cage increases in both
anteroposterior and transverse diameters [11].
The hormone relaxin, released by the corpus
luteum and placenta, results in the targeted softening of the ligamentous structures to compensate for uterine growth [12]. The diaphragm
becomes elevated due to being pushed cephalad
by the uterus, impeding the functional residual
capacity by at least 20% [11]. Tidal volume
increases and is associated with a 45% increase
in a minute and alveolar ventilation [11]. Overall
maternal metabolic rate, oxygen consumption
(VO2), gas exchange, and acid/base balance are
affected by several factors, including the growth
of the fetoplacental unit, progesterone levels, and
CO2 production.
Maternal VO2 increases by 15–20% [13]. The
resulting respiratory alkalosis is renally compensated with increased ventilation by reducing
serum bicarbonate to 20mEq/L and total buffer
base capacity to 5mEq/L [11]. Thus, the parturient is more vulnerable to hypoxemia and acidemia when critically ill, with less physiologic
reserve than nonpregnant [13]. Also, a 50%
increase in plasma volume results in dilutional
anemia and an overall rise in circulating blood
volume of 40% [11, 13]. Cardiac output increases
by 30–50%; blood ow to the gravid uterus
increased tenfold [13]. After 20weeks of gestation, the uterus size can cause a mechanical aortocaval obstruction while fully supine. The
‘supine-hypotensive syndrome’ result is a signicant loss of venous return for which the cardiovascular system cannot compensate [11].
However, most women develop collateral circulation through interosseous vertebral, paravertebral, epidural, and ovarian venous systems, less
impacted by increased IAP [11]. Those suffering
from supine-hypotensive syndrome likely do not
develop adequate collateral circulation [14].
While only approximately 8% of women at term
experience this life-threatening situation, signicant compression of the inferior vena cava while
supine occurs in most women [11, 14]. Whether
elevated IAP can exacerbate aortocaval compression and has a relationship with this syndrome is
unknown. Thus, due to the myriad of hormonal,
mechano-physiologic changes, the majority of
parturients are well compensated for the exponential growth of their fetus in a relatively short
duration of time.
3.1.3 Intra-abdominal Pressure
inNormal Pregnancy
Christian Friedrich Schatz [15] in 1872 and Carl
Schroeder [16] in 1886 suggested an adjustment
of the abdominal muscles to meet distention by
the pregnant uterus. Although with some errors,
they claimed that the pressure is 4–5 mmHg
lower in the dorsal than in the sitting or standing
positions and is negative in the knee-chest or
Соседние файлы в папке Библиотека им академика М.И. Перельмана
